FALCON POINT CAPITAL, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$235,000
+4.4%
250,0000.0%1.98%
-22.2%
Q3 2020$225,000
+2.7%
250,0000.0%2.54%
+137.1%
Q2 2020$219,000250,0001.07%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Penn Mutual Asset Management 1,214,000$1,164,0001.57%
TFG Asset Management GP Ltd 21,600,000$21,027,0001.44%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,336,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 20,472,000$19,704,0000.23%
PALISADE CAPITAL MANAGEMENT, LP 5,952,000$5,782,0000.16%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,916,0000.12%
Cutler Capital Management, LLC 300,000$287,0000.11%
Radcliffe Capital Management, L.P. 3,117,000$2,985,0000.07%
PROSPECTOR PARTNERS LLC 400,000$383,0000.06%
Financial Sense Advisors, Inc. 130,000$125,0000.05%
View complete list of LIGAND PHARMACEUTICALS INC shareholders